Insider · SEC Form 4 filer
John Treace
Past buys: 2 of 3 beat
Companies
Where they file as an insider
Treace Medical Concepts (TMCI) CEO, Director, 10% owner Latest filing Aug 24, 2026
Track record
Did their buys beat the typical stock?
Open-market buys20
Quarters checked 6 months later3
Beat the typical stock 2 of 3
Quarters too new to check2
2 of 3 checked quarters beat the typical stock. A past record is data, not a forecast.
Treace Medical Concepts (TMCI) Bought Aug 20–24, 2026 · $247K · 55,944 shares Too new Too new. Its 6-month check uses prices as of Mar 31, 2027.
Treace Medical Concepts (TMCI) Bought May 12–Jun 11, 2026 · $1.1M · 371,600 shares Too new Too new. Its 6-month check uses prices as of Dec 31, 2026.
Treace Medical Concepts (TMCI) Bought Mar 4, 2025 · $524K · 60,000 shares Behind typical Mar 31, 2025 $8.39 → Sep 30, 2025 $6.71 · −20.0% (typical stock +7.3%)
Treace Medical Concepts (TMCI) Bought Aug 14–Sep 16, 2024 · $776K · 135,000 shares Beat typical Sep 30, 2024 $5.80 → Mar 31, 2025 $8.39 · +44.7% (typical stock −7.5%)
Treace Medical Concepts (TMCI) Bought May 10–Jun 11, 2024 · $2.96M · 595,000 shares Beat typical Jun 30, 2024 $6.65 → Dec 31, 2024 $7.44 · +11.9% (typical stock +3.9%)
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.